Risperdal Breast Growth Lawsuit Goes to Trial in Philadelphia

Trial is underway in Pennsylvania state court for a Risperdal lawsuit brought against Johnson & Johnson and its Janssen subsidiary, which alleges that the drug maker failed to adequately warn that young boys prescribed the antipsychotic may experience abnormal breast growth. 

Opening arguments commenced on January 23, in a case filed by 20 year-old Austin Pledger. According to the lawsuit, Pledger indicates that side effects of Risperdal use for autism when he was 8 years old has left him with a medical condition known as gynecomastia, which has caused the growth of large female breasts that may require a double mastectomy.

The case is one of more than 1,250 similar Risperdal breast growth lawsuits currently centralized in the Philadelphia Court of Common Pleas, where mass tort proceedings have been established for the claims that allege the drug makers knew about the potential risks, yet withheld information from consumers and the medical community.

Learn More About

Risperdal Lawsuits

Side effects of Risperdal linked to risk of breast growth among young boys, or gynecomastia.

Learn More About this Lawsuit SEE IF YOU QUALIFY FOR COMPENSATION

Gynecomastia is a medical disorder associated with the growth of breast tissue among males. In many of the Risperdal cases, plaintiffs allege that the breast development caused by the medication resulted in the need for surgical treatment to remove the breasts, which will leave them with scarring and other physical injury, as well as severe psychological damage from Risperdal breast growth.

Johnson & Johnson has been quietly dealing with breast growth litigation over Risperdal for years, but the number of cases has continued to grow as more families and young adults learn that there may be a link between problems suffered following a diagnosis of gynecomastia and Risperdal use as a child.

The trial of the Pledger case is the first in what is expected to be a series of Risperdal bellwether trials this year, which are designed to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be offered throughout the litigation.

Although the outcomes of these early test trials are not binding on other cases, they may influence negotiations with Johnson & Johnson to reach Risperdal settlements in an attempt to avoid setting hundreds of individual cases for trial in the state.

1 Comments

  • RicikMarch 22, 2015 at 10:38 pm

    We feel Austin would have gotten more out of this trial, especially if he was able to give the jury a hands on account of how he had to deal with the horrors of living with gynecomastia. Johnson and Johnson are now ramping up their defense. Let's hope these multi county actions stay strong. Rick Haspery howtostopgynecomastia.com

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Management of Ozempic Lawsuit Pretrial Proceedings To Be Reassigned Following Death of MDL Judge
Management of Ozempic Lawsuit Pretrial Proceedings To Be Reassigned Following Death of MDL Judge (Posted today)

The judge overseeing Ozempic lawsuits consolidated in federal court has died, requiring a new judge to be assigned to oversee coordinated pretrial proceedings over claims the diabetes drug and similar medications caused stomach paralysis and other intestinal complications.

Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination
Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination (Posted 2 days ago)

A group of 19 plaintiffs' lawyers have been appointed to serve in various leadership position during the consolidated pretrial proceedings for all baby food injury lawsuits, taking actions that benefit all families pursuing claims for children diagnosed with autism, ADHD or other developmental problems from toxic heavy metals found in many popular products sold in recent years.